PHASE 2 RESEARCH AND DEVELOPMENT AGREEMENTPhase 2 Research and Development Agreement • April 1st, 2011 • Solazyme Inc • Industrial organic chemicals • California
* Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL...Solazyme License Agreement • April 1st, 2011 • Solazyme Inc • Industrial organic chemicals • Delaware
THIS LICENSE AGREEMENT (the “Agreement”) is made as of December 16, 2010 (the “Effective Date”) by and between Solazyme, Inc., a Delaware corporation (“Solazyme”) and Solazyme Roquette Nutritionals, LLC, a Delaware limited liability company (the “Company”). Solazyme and the Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
JOINT DEVELOPMENT AGREEMENTJoint Development Agreement • April 1st, 2011 • Solazyme Inc • Industrial organic chemicals
This Joint Development Agreement (“JDA”) is between Solazyme, Inc., a Delaware corporation (hereinafter referred to as “Solazyme”), having a principal place of business at 225 Gateway Boulevard, South San Francisco, California 94080, and The Dow Chemical Company, a Delaware corporation (hereinafter referred to as “Dow”), having an office at 2301 N. Brazosport Blvd., Building B-1211, Freeport, Texas 77541-3257. Certain terms used in this JDA are defined in Article 11.
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL...And Other Commitments From Supplier • April 1st, 2011 • Solazyme Inc • Industrial organic chemicals
It is beforehand reminded that the Supplier signed the contractual documents “Regulatory Requirements” dated October 29, 2010 and “Guarantee” dated November 4, 2010. These contractual documents are part of the present contract and the obligations of the Supplier which are detailed in these two documents are applicable to all products defined in article 2 of the Contract.
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL...Award/Contract • April 1st, 2011 • Solazyme Inc • Industrial organic chemicals
This is a firm-fixed-price research and development contract. Payments will be made in accordance with DFARS Clause 252.232-7003, Electronic Submission of Payment, see Section G.1 Invoice. Solazyme is required only to exercise its best efforts to achieve the performance, volume, and schedule objectives set forth in Section C.
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL...Manufacturing Agreement • April 1st, 2011 • Solazyme Inc • Industrial organic chemicals • Delaware
This MANUFACTURING AGREEMENT (the “Agreement”), dated as of December 16, 2010 (the “Effective Date”), is made by and between Roquette Frères, S.A., a French société anonyme (“Roquette”) and Solazyme Roquette Nutritionals, LLC, a Delaware limited liability company (the “Company”). Roquette and the Company are each referred to herein as a “Party” and collectively as the “Parties.” For the purposes of Section 2.9, Article 5 and Section 6.3(e), Solazyme, Inc. (“Solazyme”) shall be considered a party to this Agreement. Capitalized terms not otherwise defined herein shall have the meaning set forth in the Joint Venture and Operating Agreement dated as of November 3, 2010 (the “JVOA”) by and among the Parties and Solazyme.
